North Phoenix · care questions
Does a research label make it a treatment?
Research use only means a product is labelled for research. It is not a sign that a person has assessed your health or prescribed care.
A label is not the whole story
The Food and Drug Administration (FDA), the U.S. drug agency, has challenged research-labelled products marketed for people to use. Its record dated September 26, 2026 warns of possible harm from these products, whose quality is unknown.
- Human treatment claims on a sales page can show that a product is being marketed as a drug, despite the research label.
- In letters to sellers, FDA has treated mixing accessories and preparation guides as evidence of intended human injection.
- Those warning letters say what FDA believes particular businesses did wrong. They are not decisions made by a court.
Check the named substance
No product containing BPC-157, ipamorelin or retatrutide had U.S. approval in the search dated September 26, 2026.
- Under FDA’s U.S. rules, a compounded medicine—one made to order—cannot contain retatrutide or cagrilintide.
- FDA lists requests to allow certain peptide ingredients in medicines made to order. The people or groups who made those requests took them back. FDA still lists safety concerns beside those ingredients. Taking a request back does not mean FDA has approved the ingredient for that use.
- Ask for the exact ingredient and how it would be taken, such as by tablet or injection. A headline about peptides as a group is not enough.
Turn an advert into a question
Save the claim that caught your attention. Ask a person licensed to provide care whether the product is approved and what other care fits your goal.
- Is there an approved medicine for the condition I want assessed?
- What evidence is from people, rather than cells or animals?
- What remains unknown about the proposed treatment?